Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2012
Reporting Period: Second Quarter of 2012
This filing serves as a notification that the Company issued a press release announcing its financial results for the second quarter of 2012. The detailed financial data is contained in the press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) incorporated by reference, rather than within the body of this 8-K form.
Key Financial Metrics
The text of this specific Form 8-K filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release and supplemental website information.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely references the issuance of the Q2 2012 results announcement.
Guidance, Outlook, and Risks
This filing does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. Such information is expected to be found in the referenced Exhibit 99.1 (Press Release) and Exhibit 99.2 (Supplemental Information).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 25, 2012) for specific Q2 2012 revenue and earnings figures.
- Access Exhibit 99.2 (Supplemental Information on www.bms.com) for detailed segment performance and margin analysis.
- Verify year-over-year comparisons and management's commentary on the results in the referenced press release.
- Check for any updated full-year guidance provided in the press release.